HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

LN 1-255

structure in first source

Also Known As:

LN-1-255

Networked: 2 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Beceiro, Alejandro: 2 articles (10/2019 - 11/2017)
2.	Bonomo, Robert A: 2 articles (10/2019 - 11/2017)
3.	Bou, Germán: 2 articles (10/2019 - 11/2017)
4.	González-Bello, Concepción: 2 articles (10/2019 - 11/2017)
5.	Maneiro, María: 2 articles (10/2019 - 11/2017)
6.	Martínez-Guitián, Marta: 2 articles (10/2019 - 11/2017)
7.	Poza, Margarita: 2 articles (10/2019 - 11/2017)
8.	Vázquez-Ucha, Juan Carlos: 2 articles (10/2019 - 11/2017)
9.	Buynak, John D: 1 article (10/2019)
10.	Conde-Pérez, Kelly: 1 article (10/2019)

Related Diseases

1.	Pneumonia (Pneumonitis) 10/01/2019 - "The aim of this study was to compare the efficacy of LN-1-255 with that of imipenem in murine pneumonia using A. "
2.	Infections 11/01/2017 - "LN-1-255 represents a potential new β-lactamase inhibitor that may have a significant role in eradicating infections caused by A. " 10/01/2019 - "Imipenem treatment combined with LN-1-255 treatment significantly reduced the severity of infection by carbapenem-resistant A. " 10/01/2019 - "Therapeutic Efficacy of LN-1-255 in Combination with Imipenem in Severe Infection Caused by Carbapenem-Resistant Acinetobacter baumannii."

Related Drugs and Biologics

1.	Imipenem
2.	Carbapenems (Carbapenem Antibiotics)